Business Context and Reporting Period
Company: Cardiff Oncology, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 28, 2021
Reporting Period: Single event date (June 28, 2021)
This filing reports a corporate governance and market status event rather than a financial reporting period. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol CRDF.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is limited to reporting an index inclusion event and does not contain financial statements or performance data.
Material Changes
Index Inclusion: Effective June 28, 2021, Cardiff Oncology, Inc. was added to the following indices as part of the 2021 Russell indexes reconstitution:
- Russell 2000 Index (Small-cap)
- Russell 3000 Index (All-cap)
- Russell Microcap Index
This change is effective upon the U.S. market open on the date of the report.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document solely serves to disclose the index inclusion event and references a press release (Exhibit 99.1) for further details.
Investor Verification Checklist
- Verify the effective date of index inclusion (June 28, 2021) against market data.
- Review the referenced press release (Exhibit 99.1) for any additional context regarding the index reconstitution.
- Confirm the company's current trading symbol (CRDF) and exchange (Nasdaq Capital Market).
- Note that this filing does not update financial performance; refer to the most recent 10-Q or 10-K for financial metrics.